TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway
Yeye Guo1,2,3,4,5, Xu Zhang1,2,3,4,5, Jie Li1,2,3,4,5
1Department of Dermatology Xiangya Hospital Central South University Changsha China.
Abstract:
Autophagy and apoptosis are essential processes that participate in cell death and maintain cellular homeostasis. Dysregulation of these biological processes results in the development of diseases, including cancers. Therefore, targeting the interaction between apoptosis and autophagy offers a potential strategy for cancer therapy. Melanoma is the most lethal skin cancer. We previously found that tumor necrosis factor receptor-associated factor 6 (TRAF6) is overexpressed in melanoma and benefits the malignant phenotype of melanoma cells. Additionally, TRAF6 promotes the activation of cancer-associated fibroblasts in melanoma. However, the role of TRAF6 in autophagy and apoptosis remains unclear. In this study, we found that knockdown of TRAF6 induced both apoptosis and autophagy in melanoma cells. Transcriptomic data and real-time PCR analysis demonstrated reduced expression of autophagy related 16 like 2 (ATG16L2) in TRAF6-deficient melanoma cells. ATG16L2 knockdown resulted in increased autophagy and apoptosis. Mechanism studies confirmed that TRAF6 regulated ATG16L2 expression through c-Jun. Importantly, targeting TRAF6 with cinchonine, a TRAF6 inhibitor, effectively suppressed the growth of melanoma cells by inducing autophagy and apoptosis through the TRAF6/c-Jun/ATG16L2 signaling pathway. These findings highlight the pivotal role of TRAF6 in regulating autophagy and apoptosis in melanoma, emphasizing its significance as a novel therapeutic target for melanoma treatment.
Insights
Targeting tumor necrosis factor receptor-associated factor 6 (TRAF6) in melanoma induces apoptosis and autophagy. Inhibiting TRAF6 with cinchonine suppresses melanoma growth by activating the TRAF6/c-Jun/ATG16L2 pathway, offering a new therapeutic strategy.
Area of Science:
- Cellular biology
- Cancer research
- Molecular oncology
Background:
- Autophagy and apoptosis are critical for cellular homeostasis; their dysregulation contributes to cancer development.
- Tumor necrosis factor receptor-associated factor 6 (TRAF6) is overexpressed in melanoma and promotes its malignant phenotype.
- The specific roles of TRAF6 in melanoma cell autophagy and apoptosis were previously unclear.
Purpose of the Study:
- To investigate the role of TRAF6 in regulating autophagy and apoptosis in melanoma cells.
- To elucidate the molecular mechanisms underlying TRAF6-mediated regulation of these processes.
- To evaluate the therapeutic potential of targeting TRAF6 in melanoma.
Main Methods:
- Gene knockdown of TRAF6 and autophagy related 16 like 2 (ATG16L2) in melanoma cells.
- Transcriptomic analysis and real-time PCR to assess gene expression.
- Mechanism studies involving c-Jun and TRAF6 inhibition using cinchonine.
Main Results:
- TRAF6 knockdown induced both apoptosis and autophagy in melanoma cells.
- TRAF6 deficiency led to reduced ATG16L2 expression, which in turn increased autophagy and apoptosis.
- TRAF6 regulates ATG16L2 expression via the c-Jun pathway.
- Cinchonine, a TRAF6 inhibitor, suppressed melanoma cell growth by inducing apoptosis and autophagy.
Conclusions:
- TRAF6 plays a crucial role in controlling autophagy and apoptosis in melanoma.
- The TRAF6/c-Jun/ATG16L2 signaling pathway is a key mechanism in melanoma progression.
- Targeting TRAF6 represents a promising therapeutic strategy for melanoma treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...


